Switching anti-VEGF agent for wet AMD: evaluation of impact on visual acuity, treatment frequency and retinal morphology in a real-world clinical setting

PURPOSE: The aim of the present cross-sectional real-world study is to evaluate the impact of switch of anti-VEGF agent from ranibizumab to aflibercept on visual acuity, treatment frequency and retinal morphology after 12 months in eyes with ongoing chronic treatment for wet age-related macular dege...

Descripción completa

Detalles Bibliográficos
Autores principales: Granstam, Elisabet, Aurell, Sandra, Sjövall, Kersti, Paul, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Retinal Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352837/
https://www.ncbi.nlm.nih.gov/pubmed/33415353
http://dx.doi.org/10.1007/s00417-020-05059-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352837/
https://www.ncbi.nlm.nih.gov/pubmed/33415353
http://dx.doi.org/10.1007/s00417-020-05059-y

Ejemplares similares